University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today—an inability to get patients off treatment.
Feb 16, 2016
1
58
After a long series of experiments, researchers at the Stanford University School of Medicine have identified a unique cell marker that they say allows them to pick out the most fundamental form of the stem cell that gives ...
Feb 11, 2016
0
53
Ayami Yoshimi, M.D., Ph.D., of the University of Freiburg, Germany, and colleagues examined the use of peripheral blood stem cells and bone marrow as stem cell sources for hematopoietic stem cell transplantation in patients ...
Jan 12, 2016
0
3
A study directed by Paul Frenette, M.D., is featured on the cover of today's print edition of Science. In experiments involving mice, Dr. Frenette and his colleagues have solved a mystery surrounding the development of hematopoietic ...
Jan 11, 2016
0
2
A study by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) has identified a new mechanism through which hematopoietic stem cells (HSCs) control both their own proliferation and the ...
Jan 8, 2016
0
12
A team of researchers have discovered a new way for early detection of a potentially deadly fungal infection in patients with suppressed immune systems such as those being treated for leukemia or have had an organ transplant.
Dec 14, 2015
0
2
Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease ...
Nov 24, 2015
0
1
Scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) have determined how the body responds during times of emergency when it needs more blood cells. In a study published in Nature, researchers ...
Nov 16, 2015
0
76
FUJIFILM Corporation today announced to conduct a clinical trial of its anti-cancer drug FF-10101 in patients with relapsed or refractory acute myeloid leukemia (AML) in the United States next year. FF-10101 is a new drug ...
Nov 10, 2015
0
13
More than 40 percent of older patients with acute myeloid leukemia (AML) can remain in long-term cancer remission through a modified, less aggressive approach to donor stem cell transplantation, according to the results of ...
Nov 4, 2015
0
11
